Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease.
Charlson Comorbidity Index score (CCIS)
composite scoring system
diffusion capacity of lung for carbon monoxide
idiopathic pulmonary fibrosis (IPF)
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
19
11
2020
pubmed:
20
11
2020
medline:
20
11
2020
Statut:
ppublish
Résumé
Prognostic factors have yet to be established for patients with interstitial lung disease (ILD). We aimed to clarify whether the Charlson Comorbidity Index score (CCIS) could help predict disease prognosis in patients with ILD. Among ILD patients treated between April 2013 and April 2017, we retrospectively assessed the relationship between baseline clinical parameters including age, sex, CCIS, ILD diagnosis, pulmonary function test results, and 3-year ILD-related events including cause-specific death and first acute exacerbation (AE). We assessed 180 patients (mean age, 74 years), all of whom underwent pulmonary function testing including percentage predicted diffusion capacity for carbon monoxide (%D This composite scoring system accounting for IPF diagnosis, CCIS, and %D
Sections du résumé
BACKGROUND
BACKGROUND
Prognostic factors have yet to be established for patients with interstitial lung disease (ILD). We aimed to clarify whether the Charlson Comorbidity Index score (CCIS) could help predict disease prognosis in patients with ILD.
METHODS
METHODS
Among ILD patients treated between April 2013 and April 2017, we retrospectively assessed the relationship between baseline clinical parameters including age, sex, CCIS, ILD diagnosis, pulmonary function test results, and 3-year ILD-related events including cause-specific death and first acute exacerbation (AE).
RESULTS
RESULTS
We assessed 180 patients (mean age, 74 years), all of whom underwent pulmonary function testing including percentage predicted diffusion capacity for carbon monoxide (%D
CONCLUSIONS
CONCLUSIONS
This composite scoring system accounting for IPF diagnosis, CCIS, and %D
Identifiants
pubmed: 33209409
doi: 10.21037/jtd-20-1302
pii: jtd-12-10-5774
pmc: PMC7656418
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5774-5782Informations de copyright
2020 Journal of Thoracic Disease. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-1302). The authors have no conflicts of interest to declare.
Références
Rev Esp Cardiol. 2004 Sep;57(9):842-9
pubmed: 15373990
Am J Respir Crit Care Med. 2003 Sep 1;168(5):543-8
pubmed: 12773329
Respir Res. 2016 Oct 18;17(1):131
pubmed: 27756398
Respiration. 2012;83(1):20-7
pubmed: 21912082
Am J Respir Crit Care Med. 2003 Sep 1;168(5):531-7
pubmed: 12791580
Ann Intern Med. 2012 May 15;156(10):684-91
pubmed: 22586007
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Chest. 2007 Jul;132(1):214-20
pubmed: 17400667
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
PLoS One. 2016 Mar 29;11(3):e0151425
pubmed: 27023440
Stat Med. 2011 May 10;30(10):1105-17
pubmed: 21484848
Chest. 2014 Apr;145(4):723-728
pubmed: 24114524
BMC Pulm Med. 2017 Aug 15;17(1):112
pubmed: 28806935
Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43
pubmed: 17585107
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372
pubmed: 30913371
J Thorac Dis. 2019 Jun;11(6):2448-2457
pubmed: 31372282
BMC Pulm Med. 2019 Nov 27;19(1):223
pubmed: 31771541
Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42
pubmed: 12773325
Respir Res. 2016 Jul 11;17(1):79
pubmed: 27401332
Am J Respir Crit Care Med. 2005 Mar 15;171(6):639-44
pubmed: 15640368
Indian J Surg. 2018 Feb;80(1):54-60
pubmed: 29581686